Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05697874 · ClinicalTrials.gov registry record
International Rare Brain Tumor Registry
A clinical trial of Astroblastoma and BCOR ITD Sarcoma, sponsored by Children's National Research Institute.
- Recruiting
- Registry status
- 5,800
- Enrollment target
- 4
- Study locations
NCT05697874 is a study of Astroblastoma and BCOR ITD Sarcoma that is actively recruiting participants, run by Children's National Research Institute. The registered enrollment target is 5,800 participants. The trial reports 4 study locations across 3 states.
The verdict
NCT05697874, a study of Astroblastoma and BCOR ITD Sarcoma, is actively recruiting participants, sponsored by Children's National Research Institute.
- RECRUITING
- Registry status
- 5,800 participants
- Enrollment target
- 4
- Study locations
Study Summary
The objective of the International Rare Brain Tumor Registry (IRBTR) is to better understand rare brain tumors through the collection of biospecimens and matched clinical data of children, adolescents, and young adult patients diagnosed with rare brain tumors.
Conditions Studied
Study Locations (4)
California
- Nathan Robison - Los Angeles
- Marie Jaeger-Krause - San Francisco
District of Columbia
- Children's National Hospital - Washington D.C.
Ohio
- Scott Raskin - Cincinnati
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5,800 participants |
| Start Date | 2023-01-01 |
| Est. Completion | 2033-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05697874
The ClinicalTrials.gov registry entry for NCT05697874 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 5,800 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Children's National Research Institute, which has 92 total studies on file at ClinicalTrials.gov.
The record links to 4 conditions, with Astroblastoma appearing as the primary indexed condition, and to 0 interventions.
NCT05697874 reports 4 study locations spanning 3 distinct geographic areas - top geographies include California, District of Columbia, Ohio.
Frequently Asked Questions
What is clinical trial NCT05697874 about?
NCT05697874 is a clinical study titled "International Rare Brain Tumor Registry". The objective of the International Rare Brain Tumor Registry (IRBTR) is to better understand rare brain tumors through the collection of biospecimens and matched clinical data of children, adolescents, and young adult patients diagnosed with rare brain tumors.
What is the current status of trial NCT05697874?
This trial is currently recruiting. The enrollment target is 5,800 participants. The study started on 2023-01-01. Estimated completion is 2033-12.
What conditions does trial NCT05697874 study?
This clinical trial studies the following conditions: Astroblastoma, BCOR ITD Sarcoma, CNS Sarcoma, Unclassified Tumor, Malignant.
Who is sponsoring clinical trial NCT05697874?
This trial is sponsored by Children's National Research Institute, which has 92 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05697874 being conducted?
This trial has 4 study locations across California, District of Columbia, Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.